These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1713277)
41. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. Mackey JR; Au HJ; Hugh J; Venner P J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367 [TBL] [Abstract][Full Text] [Related]
42. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study. Ro JY; Ayala AG; Wishnow KI; Ordóñez NG Semin Diagn Pathol; 1988 Aug; 5(3):301-11. PubMed ID: 2845546 [TBL] [Abstract][Full Text] [Related]
43. Paneth cell-like change and small cell carcinoma of the prostate. Two divergent forms of prostatic neuroendocrine differentiation. Weaver MG; Abdul-Karim FW; Srigley JR Am J Surg Pathol; 1992 Oct; 16(10):1013-6. PubMed ID: 1329569 [TBL] [Abstract][Full Text] [Related]
44. Urothelial Carcinoma with shadow cell, lipid cell and sebaceous (skin adnexal) differentiation: Clinicopathological and immunohistochemical study of 10 cases. Behzatoğlu K Ann Diagn Pathol; 2015 Oct; 19(5):314-9. PubMed ID: 26235883 [TBL] [Abstract][Full Text] [Related]
45. Small cell carcinoma of the stomach: an immunohistochemical and electron microscopic study. Morikawa Y; Tohya K; Matsuura N; Matsumoto K; Kakudo K Histol Histopathol; 1992 Oct; 7(4):629-34. PubMed ID: 1333852 [TBL] [Abstract][Full Text] [Related]
46. Primary small cell neuroendocrine carcinoma of the kidney. Morgan KG; Banerjee SS; Eyden BP; Barnard RJ Ultrastruct Pathol; 1996; 20(2):141-4. PubMed ID: 8882359 [TBL] [Abstract][Full Text] [Related]
47. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
48. Role of multidrug resistance in tumors of the genitourinary tract. Theyer G; Hamilton G Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331 [No Abstract] [Full Text] [Related]
49. Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews. Chen Z; Liu Q; Chen R; Liu Z; Li M; Ling Q; Wu L; Yang J; Liu X; Wang T; Hu Z; Guo X; Wang S; Yang W; Liu J World J Surg Oncol; 2017 Jan; 15(1):33. PubMed ID: 28125986 [TBL] [Abstract][Full Text] [Related]
50. Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder. Takehara K; Nomata K; Eguchi J; Hisamatsu H; Maruta S; Hayashi T; Koga S; Kanetake H Int J Urol; 2004 Nov; 11(11):1016-8. PubMed ID: 15509208 [TBL] [Abstract][Full Text] [Related]
51. Tripartite differentiation in a carcinoma of the duodenum. Barnhill M; Hess E; Guccion JG; Nam LH; Bass BL; Patterson RH Cancer; 1994 Jan; 73(2):266-72. PubMed ID: 8293387 [TBL] [Abstract][Full Text] [Related]
52. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859 [TBL] [Abstract][Full Text] [Related]
53. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
54. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928 [TBL] [Abstract][Full Text] [Related]
55. Small cell carcinoma of the renal pelvis: a clinicopathological, morphological and immunohistochemical study of 2 cases. Essenfeld H; Manivel JC; Benedetto P; Albores-Saavedra J J Urol; 1990 Aug; 144(2 Pt 1):344-7. PubMed ID: 2165182 [TBL] [Abstract][Full Text] [Related]
56. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936 [TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder. Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675 [TBL] [Abstract][Full Text] [Related]
58. [Clinicopathologic features of primary renal neuroendocrine carcinoma]. Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609 [No Abstract] [Full Text] [Related]
59. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma. Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749 [TBL] [Abstract][Full Text] [Related]